Page last updated: 2024-11-05

urapidil and Pancreatic Neoplasms

urapidil has been researched along with Pancreatic Neoplasms in 1 studies

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shen, SG1
Zhang, D1
Hu, HT1
Li, JH1
Wang, Z1
Ma, QY1

Other Studies

1 other study available for urapidil and Pancreatic Neoplasms

ArticleYear
Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.
    World journal of gastroenterology, 2008, Apr-21, Volume: 14, Issue:15

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-A

2008